Kelly Anderson - 09 Aug 2024 Form 4 Insider Report for Tharimmune, Inc. (THAR)

Reporting relationship: Director
Issuer ticker: THAR
Reported as of: 09 Aug 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Aug 2024, 17:18:01 UTC
Prior SEC filing: 02 Jul 2024
Next SEC filing: 03 Oct 2024
Source filing: View source filing
Reporting owner signature: /s/ Randy Milby as Attorney-In-Fact for Kelly Anderson

Key filing fact

Kelly Anderson filed Form 4 for Tharimmune, Inc. (THAR) on 12 Aug 2024.

Key facts

This page summarizes Kelly Anderson's Form 4 filing for Tharimmune, Inc. (THAR).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 12 Aug 2024, 17:18.

Change

Previous filing in this sequence was filed on 02 Jul 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

THAR transaction Derivative

Options (right to buy)

Award

Transaction value: $0
Shares: +2,353
Change %: +4.7%
Price: $0.000000
Shares after: 52,353
Date: 09 Aug 2024
Ownership: Direct
Underlying class: Common stock
Underlying amount: 2,353
Exercise price: $2.92
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On August 9, 2024, the Reporting Person was granted options ("Options") to purchase up to 2,353 shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant.